David Meeker
Vorstandsvorsitzender bei RHYTHM PHARMACEUTICALS, INC.
Vermögen: 9 Mio $ am 31.05.2024
Profil
Dr. David P.
Meeker, MD, is a Chairman at Pharvaris GmbH, a Non-Executive Chairman at Pharvaris NV, a Chairman at Trevi Therapeutics, Inc., a Chairman, President & Chief Executive Officer at Rhythm Pharmaceuticals, Inc. and an Independent Director at Turmeric Acquisition Corp.
He is on the Board of Directors at Biotechnology Innovation Organization, New England Healthcare Institute, Prize4Life, Inc. and Turmeric Acquisition Corp.
Dr. Meeker was previously employed as a President, Chief Executive Officer & Director by KSQ Therapeutics, Inc., an Independent Director by MyoKardia, Inc., an Executive Vice President & Head Sanofi-Genzyme by Sanofi, an Independent Director by Savient Pharmaceuticals, Inc., a President & Chief Executive Officer by Genzyme SAS, a Senior Vice President by Genzyme Europe BV, a Chief Operating Officer & VP-Medical Affairs by Genzyme Corp., a Director-Pulmonary Critical Care Fellowship by The Cleveland Clinic Foundation, and an Assistant Professor by The Ohio State University.
He also served on the board at Penwest Pharmaceuticals Co. He received his doctorate degree from the University of Vermont College of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.04.2024 | 174 605 ( 0,29% ) | 6 Mio $ | 31.05.2024 | |
PHARVARIS N.V.
0,23% | 01.04.2024 | 121 719 ( 0,23% ) | 2 Mio $ | 31.05.2024 |
TREVI THERAPEUTICS, INC.
0,50% | 24.04.2024 | 352 489 ( 0,50% ) | 905 897 $ | 31.05.2024 |
Aktive Positionen von David Meeker
| Unternehmen | Position | Beginn |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 20.07.2020 |
| TREVI THERAPEUTICS, INC. | Vorsitzender | 01.07.2017 |
| TURMERIC ACQUISITION CORP. | Direktor/Vorstandsmitglied | - |
| PHARVARIS N.V. | Vorsitzender | - |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Vorsitzender | 05.01.2021 |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
Prize4Life, Inc.
 Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Prize4Life, Inc. is a non-profit organization that aims to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease. Prize4Life uses powerful incentives to attract new people and drive innovation in ALS research. The American company believes that out-of-the-box thinking is necessary to find solutions to the biggest challenges in ALS research, and that critical discoveries may come from unlikely places. Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. The non-profit company was founded by Guy Yamen and Nate Boaz in 2007. | Direktor/Vorstandsmitglied | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David Meeker
| Unternehmen | Position | Ende |
|---|---|---|
| MYOKARDIA, INC. | Direktor/Vorstandsmitglied | 17.11.2020 |
| ░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von David Meeker
| University of Vermont College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| SANOFI | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| TREVI THERAPEUTICS, INC. | Health Technology |
| PHARVARIS N.V. | Health Technology |
| Private Unternehmen | 13 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Commercial Services |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Health Technology |
The Cleveland Clinic Foundation
 The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services The Cleveland Clinic Foundation operates as a non-profit academic, research, and medical center. It offers clinic and hospital care with research and education services. The company was founded by Charles Posternack, George W. Crile, Frank E. Bunts, William E. Lower and John Phillips on February,5 1921 and is headquartered in Cleveland, OH. | Health Services |
Genzyme SAS
 Genzyme SAS BiotechnologyHealth Technology Genzyme SAS develops biotechnology solutions. Its therapeutic areas include gaucher, fabry, and pompe desease, thyroid cancer, and multiple sclerosis. The company was founded in 1981 and is headquartered in Saint-Germain-en-Laye, France. | Health Technology |
Prize4Life, Inc.
Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Prize4Life, Inc. is a non-profit organization that aims to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease. Prize4Life uses powerful incentives to attract new people and drive innovation in ALS research. The American company believes that out-of-the-box thinking is necessary to find solutions to the biggest challenges in ALS research, and that critical discoveries may come from unlikely places. Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. The non-profit company was founded by Guy Yamen and Nate Boaz in 2007. | Commercial Services |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Health Technology |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Turmeric Acquisition Corp. operates as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 28, 2020 and is headquartered in Cambridge, MA. | Finance |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Health Technology |